Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or District of Columbia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to District of Columbia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. District of Columbia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Bilal Yousufzai (NPI 1023458916)

Field	Value
Entity Type	Individual
Organization	Bilal Yousufzai
Address	110 Irving St Nw
City	Washington
State	DC
ZIP	20010
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 25, 2013

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider’s Medicare activity represents the entirety of recorded public-payer revenue: Total Medicare revenue is $1.6M and there is no Medicaid billing on file, so the practice is effectively single-payer (Medicare) in the dataset. The NPI was enumerated 2013-06-25 (~13 years ago), indicating an established billing history rather than a new registrant.

Revenue is highly concentrated in a very small set of codes — the precomputed top 3 Medicare codes account for 84.3% of this provider's total Medicare revenue. Those top three are J0178 ($776.3K, 49.9%), J2777 ($395K, 25.4%), and 92014 ($139.7K, 9.0%), which together drive the bulk of receipts and therefore represent primary operational and reimbursement risk areas.

The CPT/HCPCS mix indicates a procedure- and retina-focused ophthalmology practice: large shares come from intravitreal injection codes J0178 (aflibercept) and J2777 (faricimab), supported by vitreous injection 67028 and retinal imaging 92134. High revenue and claim counts for anti-VEGF biologics (J0178, J2777) plus imaging (92134) are consistent with a practice oriented toward recurrent therapeutic injections and retina disease management rather than general primary eye care.

Competitive standing for the principal injection codes is modest nationally: J0178 ranks #1151 of 3204 providers (64th percentile) and J2777 ranks #766 of 2039 providers (62th percentile), each labeled as "typical, unremarkable volume" in the supplied data. By contrast, 92014 is an outlier in exam volume — it ranks #604 of 35415 providers (98th percentile) and is flagged an "extreme outlier," indicating this provider bills far more comprehensive established exams than nearly all national peers.

Imaging and diagnostic services are also elevated relative to peers: 92134 has 1.7K claims and $53.8K revenue (3.5% of Medicare revenue) and ranks #1291 of 26868 providers (95th percentile), described as "notably above typical national volume." This combination of above-typical retinal imaging and high comprehensive exam volume suggests both active diagnostic throughput and follow-up visit capacity that support the sustained injection program.

The practice’s revenue mix skews heavily to drug administration and procedure codes rather than office E/M visits: 99214 and 99213 together account for only $10K and $2.1K respectively (0.6% and 0.1% of Medicare revenue), while drug/injection codes account for the lion’s share. That pattern implies the business model is centered on recurring procedural care (injections and imaging) rather than generating revenue primarily through E/M encounters.

There is limited use of unclassified biologics and alternative agents: J3590 shows 28 claims and $59.2K revenue (3.8% of Medicare revenue) and J9035 (bevacizumab) contributes $4.1K, but the dominant biologic revenue is from J0178 and J2777. This suggests occasional use of other products or billing pathways, but those are small contributors compared with the two leading anti-VEGF codes.

Absence of Medicaid billing on file is a notable business and access signal: with "none below" reported for Medicaid CPT/HCPCS, the provider lacks Medicaid-derived revenue in the record, which reduces payer diversification and may reflect limited participation in Medicaid or a patient base concentrated in Medicare-eligible populations. For payer/market analysts, this single-payer concentration (Medicare only) combined with the 84.3% top-3-code concentration highlights both revenue predictability tied to Medicare policy and vulnerability to shifts in reimbursement or biologic utilization patterns.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,130	$690	$776.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	13,620	$30	$395K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,520	$90	$139.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	810	$100	$78K
J3590	Unclassified biologics	30	$2,120	$59.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,740	$30	$53.8K
J2778	Injection, ranibizumab, 0.1 mg	170	$190	$31.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	120	$90	$10K
J9035	Injection, bevacizumab, 10 mg	70	$60	$4.1K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	20	$110	$2.6K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. District of Columbia Distribution

Bilal Yousufzai — 3 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — District of Columbia

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	10	160	$690	$390.2K
J2777	1	10	5,460	$30	$215.2K
J3590	1	10	30	$2,120	$59.3K
J2778	2	10	220	$180	$41K
92014	3	50	100	$90	$26.2K
67028	2	10	170	$100	$25K
99214	576	1,400	90	$100	$15.3K
99213	811	1,200	50	$70	$8.5K
92134	2	50	120	$30	$8.3K
92004	14	30	30	$100	$5.9K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Bilal Yousufzai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Marietta Eye Clinic, PA	GA	Ophthalmologic Surgery Clinic/Center	$2.5M	$0
Annal Meleth	GA	Ophthalmology Physician	$2.2M	$0
Lakshmana Kooragayala	GA	Ophthalmology Physician	$1.8M	$0
Jared Cox	GA	Optometrist	$23.3K	$525.1K
Justin Wilkin	GA	Ophthalmology Physician	$354.5K	$0
Puneet Panda	GA	Ophthalmology Physician	$257.2K	$0
Andre Cohen	GA	Ophthalmology Physician	$239.2K	$0
Byron Long	GA	Ophthalmology Physician	$208.2K	$0
Charles Ho	GA	Ophthalmology Physician	$186.3K	$0
Denise Johnson	GA	Ophthalmology Physician	$165.1K	$0

Nearby Providers

Other providers in the same ZIP code as Bilal Yousufzai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Children's Hospital	DC	Children's Hospital	$0	$243.1M
Medstar Washington Hospital Center	DC	General Acute Care Hospital	$0	$239M
Children's Hospital	DC	Pediatrics Physician	$0	$115.3M
Whc Physician Group LLC	DC	General Practice Physician	$0	$93.8M
Medstar Medical Group Radiology, LLC	DC	Diagnostic Radiology Physician	$0	$17.5M
National Rehabilitation Hospital Inc	DC	Rehabilitation Hospital	$0	$16.9M
Hero Dental Of Washington Dc PC	DC	General Practice Dentistry	$0	$11.7M
Medstar Heart Institute LLC	DC	Surgery Physician	$0	$4.8M
Bio-medical Applications Of Columbia Heights, Inc.	DC	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$4.6M
Washington Hospital Center Corp	DC	General Practice Physician	$0	$3.7M

Bilal Yousufzai — Billing Profile & Reimbursement Data

Sign up for Bilal Yousufzai — Billing Profile & Reimbursement Data policy alerts

Bilal Yousufzai — Billing Profile & Reimbursement Data

Sign up for Bilal Yousufzai — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References